Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06460246
Other study ID # Pro00077383
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date June 25, 2024
Est. completion date July 31, 2024

Study information

Verified date June 2024
Source Acurable Ltd.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This project aims to test the accuracy of pulse oximeters in the range of arterial HbO2 saturations from 100% down to 70%.


Description:

This project aims to test the accuracy of pulse oximeters in the range of arterial HbO2 saturations from 100% down to 70%. This is done by comparing the pulse oximeter reading during brief, steady state hypoxia plateaus with a gold-standard measurement of blood oxyhaemoglobin saturation.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 12
Est. completion date July 31, 2024
Est. primary completion date June 27, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria: - Male or female, aged >= 18 and < 50. - Subject in good general health with no evidence of any medical problems. - Subject is fluent in both written and spoken English. - Subject has provided informed consent and is willing to comply with the study procedures. Exclusion Criteria: - Subject is obese (BMI > 35). - Subject has a known history of heart disease, lung disease, kidney, or liver disease. - Diagnosis of asthma, sleep apnea, or use of CPAP. - Subject has diabetes. - Subject has a clotting disorder. - Subject has hemoglobinopathy or history of anemia, per subject report or the first blood sample, that in the opinion of the investigator, would make them unsuitable for study participation. - Subject has any other serious systemic illness. - Subject is a current smoker. - Any injury, deformity, or abnormality at the sensor sites that in the opinion of the investigators would interfere with the sensors working correctly. - Subject has a history of fainting or vasovagal response. - Subject has a history of sensitivity to local anesthesia. - Subject has a diagnosis of Raynaud's disease. - Subject has unacceptable collateral circulation based on exam by the investigator (Allen's test). - Subject is pregnant, lactating, or trying to get pregnant. - Subject is unable or unwilling to provide informed consent, or is unable or unwilling to comply with study procedures. - Subject has any other condition, which in the opinion of the investigators would make them unsuitable for the study.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Pulse Oximeter
The subjects will have a 22-gauge catheter inserted in the radial artery to measure the oxygen saturation of arterial blood and also wear pulse oximeters.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Acurable Ltd.

Outcome

Type Measure Description Time frame Safety issue
Primary Performance of the pulse oximeters against corresponding arterial blood oxygen saturation. Performance of the pulse oximeters against corresponding arterial blood oxygen saturation. 1-4 hours
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1